Clinical Trials Directory

Trials / Completed

CompletedNCT01408537

Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
152 (actual)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
1 Year – 3 Years
Healthy volunteers
Accepted

Summary

Japanese encephalitis (JE) is the main cause of viral encephalitis in many countries of Asia including Thailand. Estimated annual mortality ranges from10,000-15,000 deaths, while the total number of clinical cases is about 50,000. Of these cases, about 50% result in permanent neuropsychiatric sequelae. The disease occurs mostly among children aged \<10 years. There is no specific antiviral treatment for JE. Vaccination is the single most important control measure. This study aims to evaluate the immunogenicity and safety of inactivated Vero cell derived JE vaccine (Beijing P-3 strain) produced by Liaoning Cheng Da Biotechnology Co., Ltd, China "JEVAC" in Thai children. 152 healthy Thai children aged between 1-3 years will be vaccinated with "JEVAC" in a dose of 0.5 mL. subcutaneously on Day 0, 1-4 weeks later and a booster vaccination at one year (totally 3 doses). Two mL. of blood will be drawn on Day 0, 4 weeks after second dose, at one year on booster vaccination day and 4 weeks after the booster (totally 8 mL. of 13 months study period) for determination of JE neutralizing antibodies (PRNT50) using Beijing P3 strain. Adverse events will be observed for 28 days after each vaccination. Serious adverse events will be observed throughout the study period.

Conditions

Interventions

TypeNameDescription
BIOLOGICALJEVACEach subject will receive 3 doses of JEVAC subcutaneously on Day 0, 1-4 weeks and a booster vaccination at one year. Each dose of JEVAC contains 0.5 mL. of inactivated Vero cell derived JE vaccine (Beijing P-3 strain).

Timeline

Start date
2010-05-01
Primary completion
2012-10-01
Completion
2012-12-01
First posted
2011-08-03
Last updated
2014-11-18
Results posted
2014-11-18

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01408537. Inclusion in this directory is not an endorsement.